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ABSTRACT
Background:  C-Reactive  Protein (CRP)  
levels  were  found  increase  in  ST  elevation 
myocardial  infarction (STEMI) patients, before and 
after STEMI. Increase of CRP levels were able to 
activate complement pathway to induce 
inflammation by attracting neutrophil and 
macrophage to enter to infarcted myocardial.  
Infarct expansion followed by remodeling process, 
led to left ventricular dysfunction and decrease of 
ejection fraction.
Aim: This study aimed to investigate a 
correlation between CRP plasma levels and left 
ventricular ejection fraction (LVEF) in anterior 
STEMI patients.
Subject and method: This study was 
conducted cross-sectionally. Subjects were new 
anterior STEMI patients, with maximum onset of 48 
hours. Exclusion criteria included  evidence of 
infection, inflammation, history of surgery or stroke 
in last three months, malignancy, congestive heart 
failure and inferior STEMI. There were 30 subjects 
who met  the eligible criteria. CRP blood samples 
were collected at least 48 hours after onset.  LVEF 
measurement was done during   hospitalization. The 
correlation between CRP levels and LVEF was 
analyzed by Spearman rank correlation test. 
Result: CRP levels in female subjects were 
higher than males [CRP median 23.4 mg/l (5.73 – 
61.4 mg/l) vs. 12. 2 mg/l (5.6 – 66.5 mg/l)], but with 
no significance (P= 0.297). The thrombolytic 
therapy group had lower CRP levels than non 
thrombolytic therapy group [10. 7 mg/l (5.6 – 44.5 
mg/l) vs. 14.7 mg/l (8.7 – 66.5 mg/l), also with no 
significance (P= 0.178). There was a non-
significantly negative correlation between CRP 
level and LVEF (r = - 0.100, P= 0.597).
Conclusion: There was no correlation 
between CRP level and LVEF in anterior STEMI.
Keywords:  STEMI – C-reactive protein – 
inflammation –  left ventricular ejection fraction.
INTRODUCTION
ST elevation myocardial infarction 
(STEMI) was a spectrum of acute coronary 
syndrome (ACS),  the rupture s tage of  
atherosclerotic plaque. Inflammatory process  
involved in all of atherosclerotis stages, since fatty 
1streak formation to plaque rupture . In myocardial 
infarction patients, inflammatory process also 
related to the expansion of myocardial necrosis that 
affect short and long term outcome in post STEMI 
2.3and non NSTEMI patients .
Acute phase protein was a non specific 
protein produced by hepatocyte as a response to 
inflammatory cytokines i.e. interleukin-1 (IL-1). IL-
6 and tumor necrosis factor-α (TNF-α) released by 
tissue damage, infectious conditions, inflammatory 
4disorder and malignancy . C-reactive protein (CRP) 
as a positive acute  phase  protein  play  a  role  in  
the development of  post  myocardial  infarction 
complications, such as ventricular wall rupture, 
aneurysm, papillary muscles rupture, infarct  
expansion,  remodeling  and  ventricular  
2.3dysfunction . C-reactive protein was able to 
activate complement system that could lead 
neutrophil and macrophage enter myocardium 
5.6leading to necrosis expansion . 
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Study Protocol
Subjects who fulfilled inclusion and 
exclusion criteria underwent ECG examination at 
baseline with 12 leads on extremities and precordial. 
All changes of ST segment were recorded. Five milli 
liter of blood was collected to examine CRP levels by 
chemiluminescent method using Immulite 2000 
device. This procedure was performed at Prodia 
Laboratory. Total time of CRP collection (hours) was 
measured from the onset of pain until blood 
collection. The maximum CRP collection was 48 
hours. Echocardiography examination was 
conducted at ICCU by cardiologists during 
hospitalization and LVEF was measured by M-Mode 
method. Normal value of LVEF was ≥ 40%.
Statistical  Analysis
Subject characteristics were presented as 
proportion mean+standard deviation (SD) and 
median (minimum-maximum). Unpaired t-test was 
used to analyze the difference of normal distribution 
data. Data with abnormal distribution were analyzed 
using Mann Whitney U test. The correlation between 
CRP levels and LVEF was analyzed by Spearman rho 
test. For all  statistical analysis  a  p-value  of  <0.05  
indicates  significance.
RESULTS
There were 30 subjects who fulfilled 
inclusion and exclusion criteria. Table 1 displayed 
Subjects' characteristics. The CRP levels of female 
subjects were higher than male, i.e. 23.4 mg/l (5.73 – 
61.4 mg/l) compared to 12.2 mg/l (5.6 – 66.5 mg/l), 
but not statistically significant (P = 0.297) (table 2). 
The CRP levels also seem higher in non thrombolytic 
group than thrombolytic group (table 3).
Volume 2, Number 1, June 2012 Correlation Between C-Reactive Protein and Left Ventricular Ejection
Left ventricular systolic dysfunction in post 
STEMI patients cause cardiac failure that consist of 
cardiac output and left ventricular ejection fraction 
7.8. (LVEF) declining Infract expansion and left 
ventricular dysfunction often occured in anterior 
infarction rather than inferior infarction. This 
condition occurred in first 10 days after STEMI and 
9associated to prognosis . Left ventricular ejection 
fraction measurement was a technique to measure 
left ventricular systolic function. one of the methods 
is M-Mode or Simpson method. The use of Simpson 
method in echocardiography to measure LVEF did 
99m not significantly differ to Technetium radionuclide 
10ventriculography . Based on the data mentioned 
above, this study was conducted to measure the  
correlation between CRP levels and LEVF in 
anterior STEMI patients.
METHOD
This study was cross sectional conducted 
aiming at determining correlation between CRP 
levels and ejection fraction in anterior STEMI 
patients. Study population included anterior STEMI 
patients who were admitted to ICCU department of 
Dr. Sardjito Hospital Yogyakarta. Patients presented 
with new anterior STEMI with onset of pain 
maximum 48 hours and were willing to participate. 
Exclusion criteria included patients with signs and 
symptoms of infection, inflammatory disorders, 
history of surgery or stroke in the last three months, 
malignancy, congestive heart failure and inferior 
STEMI.
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Table 1. Baseline characteristics of study subjects (n=30)
Characteristics mean±SD  
(Proportion)
 
CI 95%  Median  Minimum 
–
 
Maximum
Age (years)
 
58.46±10.46
 
54.31-62.62
   Sex:
     ?
 
Male
 
23 (76.7%)
    ?
 
Female
 
7 (23.3%)
    Onset of Pain (hour)
   
5.5
 
2-30
 CRP time (hour)
   
8
 
3-30
 Diabetic:
     ?
 
Yes
 
2(6.7%)
    
?
 
No
 
28(93.3%)
    
Hypertension:
     
?
 
Yes
 
16(53.3%)
    
?
 
No
 
14(46.7%)
    
Smoking
     
?
 
Yes
 
16(53.3%)
    
?
 
No
 
14(46.7%)
    
Dislipidemia
     
?
 
Yes
 
3(10%)
    
?
 
No
 
27(90%)
    
Blood pressure (mmHg)
     
?
 
Systolic
 
123.73±26.48
 
113.04-134.42
   
?
 
Diastolic
   
80
 
56-105
Laboratory
     
?
 
Leucocyte (103 /mm3)
 
13.25±3.64
 
11.78-14.72
   
?
 
CKMB (IU/I)
   
34.6
 
11-208
?
 
LDH (IU/I)
   
740.5
 
378-2675
?
 
AST (IU/I)
   
65
 
24-502.8
?
 
CRP (IU/I)
   
13.5
 
5.6-66.5
?
 
Total Cholesterol (mg/dl)
 
216.31±44.3
 
198.41-234.2
   
?
 
LDL (mg/dl)
 
134.23±51.54
 
113.41-155.05
   
?
 
HDL (mg/dl)
 
43.7±9.86
 
39.72-47.68
   
?
 
TG (mg/dl)
   
128.5
 
55-587
?Glucose level (mg/dl)
  
165
 
96-429
ST Elevation (mm) 3 2-6
Ejection fraction (%) 
Trombolysis:
53.23±11.95 48.4-58.06
?Yes 17(56.7%)
?No 13(43.3%)
Note: AST = aspartate aminotransferase, CKMB = creatin kinase MB, CRP = C-Reactive Protein, HDL = 
high density lipoprotein, CI 95% = confidential interval 95%, LDH = lactic dehydrogenase, LDL = low 
density lipoprotein, TG = trigliseride. 
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Table2. Distribution of C-reactive protein levels (mg/L) by sex (n= 300)
Table 3. Distribution of C-reactive protein levels (mg/L) by thrombolytic therapy (n=30)
Sex Mean±SD Median Minimum-
Maximum
 P S/NS
Male
 
(N= 22)
 
18.49±15.58
 
12.2
 
5.6
 
–
 
66.5
 
0.297
 
NS
 
Female (N= 7) 26.18±20.47 23.4 5.73  –  61.4    
Thrombolytic Mean±SD Median  Minimum  –  P  
Therapy   Maximum   Done
 
(N = 17)
 
16.64±13.42
 
10.7
 
5.6
 
–
 
44.5
 
0.178
 Not done (N = 13) 25.05±19.93 14.7 8.7 – 66.5
Note: SD = standard deviation
Note: SD = standard deviation
We found negative correlation between CRP levels and LVEF (r = - 0.100 and P = 0.597) (figure 1). 
Figure 1. Correlation between C-reactive protein levels and left
ventricular ejection fraction
Volume 2, Number 1, June 2012 Correlation Between C-Reactive Protein and Left Ventricular Ejection
Acta Interna - The Journal of Internal Medicine
20
DISCUSSION
In this study, CRP levels of females were 
non-significantly higher than the ones of males 
(median 23.4 mg/l versus 12.2 mg/l) (P= 0.297). 
11Podrid  reported that female has higher CRP level 
than male and the increasing of CRP levels could be 
used to predict cardiovascular disease as in male. 
Female with increased CRP level more than 3 mg/l. 
had an 8-fold mortality risk compared to female 
12having CRP levels less than or equal to 1 mg/l . 
Female with cardiovascular disease had CRP levels 
higher than female  without cardiovascular  disease 
13(0.42 mg/l   vs. 0.28 mg/l) . Post menopause female 
that used hormonal replacement treatment (HRT) 
had CRP levels twice as much as female that did not 
13use it . Other study reported on 493 post menopause 
healthy female that the HRT user  had CRP levels 
14twice as much as the non user .
In this study there was difference of CRP 
levels between thrombolytic group and non 
thrombolytic group, even though it did not reach 
significance. A different result was reported by 
2  Pietila et al cit. Anzai et al that found that CRP 
levels of open infarct- related coronary artery were 
less than levels of closed infarct-related coronary 
artery or when compared to control group (non 
thrombolytic therapy). In control group, they found 
closed relationship between infarct size and CRP 
levels (r= 0.58; P< 0.001). This correlation was 
particularly found in closed infarct-related coronary 
artery (r= 0.62; P< 0.001). In open infarct-related 
coronary artery, the correlation between infarct size 
and CRP levels were weak (r=30;P<0.01).
Left venticular ejection fraction had inverse 
correlation with CRP levels, in control group and 
15 reperfusion group. Zairis et al found that in 319 
STEMI patients subjects with CRP levels at high 
tertile had lower ST segment resolution to normal 
limit, lower thrombolysis in myocardial infarction 
score and higher mortality caused by cardiac 
survival.
The correlation between CRP levels and 
LVEF in this study was very weak, with coefficient 
correlation (r) = - 0.100 and P = 0.597. However, 
16 Pandian et al found a closer relationship with r = - 
0. 67 and P = 0.011. Many explanations of this result 
are as follows: First, this study only included 
anterior STEMI patients resembling the inclusion 
7 done by Antman & Braunwald who found that 
anterior infarct related to the declining of cardiac 
output, congestive heart failure and cardiogenic 
9  shock. DeMaria & Blanchard reported that left 
ventricular remodeling may occur in ten days after 
STEMI and related to worse prognosis caused by 
decreasing of left ventricular  function. In 
ventricular inferior infarction, increasing of right 
cardiac filling pressure (increasing of central 
venous pressure, right atrium and right ventricular 
diastolic pressure) can be found, but left ventricular 
7filling pressure is still in normal level . Pandian et 
16 al did not discriminate  infarct location in their 
study population. Second, this study included only 
patients with new STEMI and had no congestive 
history of heart failure to avoid any interference to 
16 LVEF measurement. Pandian et al did not mention 
congestive heart failure as an exclusion criteria. 
Third, in this study, the total time for CRP sampling 
were varied, ranged from 3 hours  to  30  hours  after 
the onset  of  pain  (mean±SD =  7.46±6.98  hours). 
3 Suleiman et al found that CRP levels after 12–24 
hours of STEMI onset were independent markers of 
17 30 days mortality and heart failure. Tomassi et al
who collected CRP samples eight hours after onset 
of pain found correlation between CRP levels and 
cardiac events one year afterward. The limiting time 
for CRP sampling in the present study was set at 
admission until 48 hours after STEMI. This was 
4 based on observation by Hirschfield & Pepys
reported that CRP was produced by hepatocytes 
immediately after onset. This is induced by 
releasing of IL-6 from infarct tissue and reached 
peak levels at 48 hours when it then gradually 
decline to normal limit. Fourth, CRP levels that 
increased immediately after STEMI onset had 
relationship to less infarct size and better left 
ventricular function at post reperfusion therapy in 
anterior STEMI patients. This protective effect of 
high CRP levels was silent myocardial ischemia 
which lead to ischemic preconditioning effect at 
myocardium. Inflammatory process induced an 
increase expression of angiogenic growth factor. 
This results in decreasing of infarct size and 
increasing of endogenous nitric oxide production to 
18keep myocardium off ischemia . The correlation 
between CRP levels and LVEF in this study was 
very weak. This can be caused by time of CRP levels 
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sampling that might provide protective effect of 
high CRP levels.
This study has some limitations. The design 
of cross sectional did not allow us to take conclusion 
since exposure and outcome variables were 
measured at the same time. This study did not 
defined CRP sampling based on thrombolysis 
therapy. Left ventricular diastolic function was not 
measured despite the fact that prognosis evaluation 
in post STEMI patients is not LVEF alone. Besides, 
the examiner of LVEF was not only one person. 
Finally, LEFV technical measurement could be 
better if Simpson method is used.
CONCLUSION AND SUGGESTIONS
This study showed that there was no 
correlation between plasma CRP levels and left 
venticular ejection fraction at anterior STEMI 
patients. Further study needs to perform a 
prospective design and consider the status of 
thrombolytic therapy. CRP sampling at peak level 
(48 hours) may discover the real inflammation 
condition. Left ventricular diastolic function also 
needs to be measured beside LVEF. The LVEF can 
be assessed using Simpson method that also 
c o n s i d e r  i n t r a  a n d  i n t e r  o b s e r v e r  i n  
echocardiography examination.
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ABSTRACT
Background. Hypertension is a major risk 
for the development and progressivity complication 
of macro and microvascular of diabetes mellitus. 
Renin-angiotensin-aldosteron system (RAAS), 
insulin resistance, endothelial dysfunction and 
autonomic nervous dysfunction play an important 
part in the pathogenesis of hypertension and type 2 
diabetes mellitus. In RAAS, increased angiotensin II 
constricts arterioles, raises total peripheral 
resistance and blood volume. The rise in 
intravascular volume increases risk of hypertension. 
Glucotoxicity or hyperglycemia in type 2 diabetes 
mellitus can increases angiotensin II levels.
Aim. To evaluate plasma angiotensin II 
levels in type 2 diabetes mellitus women with or 
without hypertension.
Methods. Cross sectional design was 
conducted on subjects from outpatients' women with 
type 2 diabetes mellitus at endocrinology clinic, Dr. 
Sardj i to  General  Hospital ,  Yogyakarta.  
Hypertension was assessed using criteria from 
Seventh Joint National Committee (2003). ELISA 
sandwich method was used to measure plasma 
angiotensin II levels from blood vein. Differences 
between groups were compared by student's 
unpaired t-test and Mann-Whitney test.
Results. Among 60 subjects, there are 30 
with hypertension (50%) and 30 without 
hypertension (50%). Mean age were 54.11 ± 3.36 
years old. Plasma angiotensin II levels was higher in 
women with type 2 diabetes mellitus with 
hypertension than without hypertension although 
significance was not reached (0.30 ± 0.15 ng/mL vs. 
0.28 ± 0.18 ng/mL, p= 0.93).
Conclusion. The plasma angiotensin II 
levels are not significantly different between type 2 
diabetes mellitus women with or without 
hypertension.
Key words: hypertension, plasma angiotensin II, 
type 2 diabetes mellitus, women
INTRODUCTION
High prevalence of diabetes was a serious 
problem in the world since twenty years ago. Type 2 
diabetes or non-insulin dependent of diabetes 
mellitus (NIDDM) is the most common type of 
diabetes (85-90%). In 2003, the world health 
organization (WHO) predicted that in Indonesia 
there were 5.1% or equals to 194 million people of 
20-79 years old suffering from diabetes and this 
tends to increase in the year 2025 (almost 333 
million people). Diabetes mellitus and hypertension 
were risk factors for morbidity and mortality from 
complication of cardiovascular disease,  
cerebrovascular disease and chronic kidney disease. 
Increasing normal systolic blood pressure of about 
20 mmHg or diastolic pressure of about 10 mmHg in 
12 years had correlation with high risk mortality due 
to coronary heart disease and stroke³. Many factors 
may influence blood pressure. Renin-angiotensin-
aldosteron system (RAAS) is one of the factors that 
have an important role in controlling blood pressure 
4and sodium homeostasis .
Prevalence of hypertension in population 
with diabetes is greater than without diabetes. 
Hypertension is the most important factor in 
progressivity of chronic complications of diabetes, 
e i ther  macrovascular  or  microvascular  
4complications . The prevalence of diabetes mellitus 
increases in women because high prevalence of 
obesity in women, polycystic ovarii syndrome, 
gestational diabetes or premenopausal (due to the 
5effect of low estrogen) . 
The decreasing of estrogen in women 
influence high activity RAAS and then increasing 
angiotensin II constricts arterioles, raises total 
peripheral resistance and blood volume. The rise in 
intravascular volume increases risk of hypertension. 
